|
Sagalova O.I.
Interferon-free antiviral therapy for chronic hepatitis C
|
№2 / 2015
|
|
Lobzin Yu.V., Kuznetsov N.I., Romanova E.S.
Recombinant Il-1β in the combination therapy of chronic hepatitis C
|
№4 / 2014
|
|
Aripkhodjaeva G.Z.
The glutathione system and intoxication syndrome in chronic hepatitis C
|
№4 / 2014
|
|
Reizis A.R., Khokhlova O.N., Serebrovskaya L.V.
A new prognostic test for the efficiency of antiviral therapy for chronic hepatisis C in adults and children as a principle of personified medicine
|
№2 / 2014
|
|
Makashova V.V., Kuznetsov S.D., Floryanu A.I., Shabalina S.V.
The clinical and laboratory features of the natural course of chronic hepatitis C
|
№2 / 2014
|
|
Konstantinov D.Yu., Konstantinova E.A., Popova L.L., Strebkova E.A., Suzdaltsev A.A.
New approaches to optimizing antiviral therapy in patients with chronic hepatitis C and low baseline leukocyte content
|
№3 / 2013
|
|
Kaliaskarova K.S., Tuganbekova S.K., Kuzembaeva K.U., Konysbekova A.A., Malova E.S., Glazkova E.Ya., Balmasova I.P., Rybkina A.A., Bunkova E.B., Morozov V.G.
Genotypic profile and dynamics of viral load in patients with chronic hepatitis C during standard antiviral therapy in the representatives of Kazakh and Slavic populations in the Republic of Kazakhstan
|
№3 / 2013
|
|
Malova Е.S., Glazkova Е.Ya., Morozov V.G., Rybkina А.А., Morozov A.V., Safiullina N.Kh., Balmasova I.P.
Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C on the basis of routine laboratory indices
|
№1 / 2013
|
|
Mukomolov S.L., Levakova I.A., Sulyagina L.G., Sinaiskaya E.V., Bolsun D.D., Ivanova N.V.
Current epidemiology of hepatitis C in Russia
|
№6 / 2012
|
|
Kaliaskarova K.S., Tuganbekova S.K., Malova E.S., Glazkova E.Ya., Morozov V.G., Balmasova I.P.
Tumor necrosis factor-α and liver fibrosis in chronic hepatitis B and C patients belonging to different population groups in Kazakhstan
|
№3 / 2012
|
Русский
